.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Targeting microRNAs involved in hyperthermia-induced radiosensitivity: The future in treatment of cervical cancer?

Appointment

Date: 29/09/2023

Time: 14:24 – 14:36

Talk time: 10 Min.

Discussion time: 2 Min.

Location / Stream:

Plenary hall

Session

Hyperthermia drug delivery, Nanoparticles, Emerging applications

Topic

Other

Authors

Ms Mengfei Xu (Amsterdam, NL), Dr. Angelina Huseinovic (Amsterdam, NL), Prof. Mark van de Wiel (Amsterdam, NL), Prof. Lukas Stalpers (Amsterdam, NL), Dr. Arlene Oei (Amsterdam, NL), Prof. Renske Steenbergen (Amsterdam, NL), Dr. Barbara Snoek (Amsterdam, NL)